Christophe Javaud, Ph.D., M.B.A., Glycoengieering Yeast
Dr. Javaud is expert in glycobiology. He was co-founder and CEO and Chairman of the Board of Glycode S.A.S. (France), a VC funded innovative startup company focused on generating yeast with humanized glcoengineering to produce homogenous glycosylation of therapeutic products. He successfully closed 2 financing rounds and built a wide network of French and foreign VCs. Dr. Javaud is co- inventor of three patents in glyco-engineering of yeast. He was successful in licensing deals with major international companies. He was responsible for negotiations and management of collaborative projects (FP7, Eurostars, ISI) deals with major biotech/pharma companies such as Ceva santé animale, Lonza, LFB, Novartis, and Merck-Serono.
Dr. Javaud is a successful leader who managed a multidisciplinary team of 20 scientists and managers for Glycode and has a strong knowledge of worldwide biotech and pharma markets. He received his Ph.D. in molecular biotechnology from University of Limoges in France and his executive M.B.A. at HEC School of Management (Paris)/Babson College (Boston) with a focus on entrepreneurship and innovation.
Bruce Zamost, M.Sc., Fermentation and Process Development
Mr. Zamost has more than 25 years of experience in the development of production processes for biopharmaceuticals. He is a co-inventor on 12 patents covering the process development for recombinant products. Mr. Zamost has taken products from lab bench through large-scale industrial manufacturing including GMP manufacturing.
At Novo Nordisk and Zymogenetics (now a BMS company), he worked on the production of biopharmaceuticals in the yeast, P. methanolica and S. cerevisiae as well as E. coli. Mr. Zamost has recently worked on a project in fermentation optimization and scale-up of monoclonal antibodies using the yeast, Pichia pastoris. He received his B.A. in Microbiology and M.Sc. in Biological Sciences from Southern Illinois University in Carbondale.